Nash Huw M. 4
4 · Stoke Therapeutics, Inc. · Filed Mar 17, 2023
Insider Transaction Report
Form 4
Nash Huw M.
COO & CBO
Transactions
- Award
Employee Stock Option (Right to Buy)
2023-03-15+78,600→ 78,600 totalExercise: $9.15Exp: 2033-03-14→ Common Stock (78,600 underlying) - Award
Restricted Stock Unit (RSU)
2023-03-15+52,400→ 52,400 totalExp: 2027-03-15→ Common Stock (52,400 underlying)
Footnotes (3)
- [F1]The option vests as to 1/48th of the total shares on April 15, 2023 and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date.
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
- [F3]The RSUs vest as to 1/4th of the total shares annually beginning March 15, 2024, subject to the reporting person's continued service to the issuer through each vesting date.